GPT Healthcare Limited

GPT Healthcare Limited (GPTHEALTH) is a micro-cap Healthcare company valued at ₹1,163 crore operating in Hospital on the NSE and BSE.

Recent price move

GPT Healthcare Limited last traded at ₹139.98, modestly up 0.14% on the day.

Recent developments

On 2026-07-30, the company announced a dividend of ₹1.50 per share, ex-date. On 2026-06-30, the latest quarter ended with revenue of ₹126 crore and net profit of ₹13 crore, showing strong quarterly growth compared to the prior year's ₹8 crore net profit.

Financial performance

The company's annual revenue rose 16.1% to ₹473 crore, while annual net profit fell 15.6% to ₹42 crore. The latest quarter saw revenue increase 17.9% to ₹126 crore and net profit jump 59.1% to ₹13 crore compared to the same quarter a year earlier, though the net profit margin narrowed 3.4 percentage points to 8.9%.

Valuation multiples

The stock trades at 27.2 times earnings, a discount to the Healthcare median of 32.0, 4.90 times book value. It yields 1.6%.

Things to watch

The company's net profit margin has declined 3.4 percentage points to 8.9%, and annual net profit fell 15.6% despite revenue growth. The stock is 13.4% below its 52-week high, and the company's profit growth has slowed significantly over the past three years, with a 2.7% CAGR compared to a 15.0% CAGR over the past five years.

Where it stands

GPT Healthcare Limited ended the latest quarter with revenue of ₹126 crore and net profit of ₹13 crore, showing strong quarterly growth. The company's annual revenue grew 16.1% but net profit fell 15.6%, with the net profit margin narrowing to 8.9%. The stock is 13.4% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.